The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...
Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...
It requests that correction officers named in those federal lawsuits be appointed private counsel, including several who have been implicated in the alleged beating death of Robert L. Brooks at ...
Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...
Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...
Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of the agency.
The FDA has tapped Sara Brenner to serve as acting commissioner as it awaits new leadership from the Trump administration to ...
Brenner, who has worked in the FDA’s Center for Devices and Radiological Health, will lead the agency until a permanent ...
Brenner, who worked in the FDA’s Center for Devices and Radiological Health, will take the helm of the agency until a new ...
The Trump administration tapped Sara Brenner, a career FDA official, to serve as the acting commissioner of the agency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback